
About Deify Pharma Private Limited
Data last updated:
Deify Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2012PTC083949. Its GSTIN is 36AAECD5341E1ZY (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lakshmi Vemulawada and Nichemolla Ramesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 40 Anandnagar Colony Chinna Thokatta Bowenpally Secunderabad, Telangana, India – 500011.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr. For the same year it recorded a net profit of ₹12.8 Lakh (net margin 10.3%) and EBITDA of ₹23.47 Lakh (EBITDA margin 18.8%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website deifypharma.com.
Company details
CIN history
Deify Pharma has one previous CIN (Corporate Identification Number): U24233AP2012PTC083949. The current CIN is U24233TG2012PTC083949, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2012PTC083949 | Current |
| U24233AP2012PTC083949 | Previous |
Contact details
Deify Pharma Private Limited's registered office is in Secunderabad, Telangana. Its website is deifypharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 40 Anandnagar Colony Chinna Thokatta Bowenpally Secunderabad, Telangana, India – 500011
- IndustryPharma, Drug Formulation & Development, Pharmaceutical Retailers & Distributors
To see the full contact details of Deify Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Deify Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Deify Pharma Private Limited, buy the company report.
Financials of Deify Pharma Private Limited
FY 2025 filings availableDeify Pharma Private Limited reported revenue of ₹1.25 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over three years. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.8% | ||||
| Net Profit Margin | 10.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Deify Pharma Private Limited, buy the company report.
Board of directors of Deify Pharma Private Limited
Deify Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmi Vemulawada | Director | 01 Nov 2012 | 14 Years 0 Months | Current |
| Nichemolla Ramesh | Additional Director | 22 May 2025 | 1 Years 5 Months | Current |
Auditor
Deify Pharma Private Limited is audited by RAMANA AND CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMANA AND CO | FY 2020 | 014420S |
Shareholding
The shareholding of Deify Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Deify Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Feb 2020 | 100401133 | Others | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Deify Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deify Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Deify Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECD5341E1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Deify Pharma Private Limited, buy the company report.
Recent activity
Deify Pharma Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Nichemolla Ramesh was appointed as Additional Director on 22 May 2025.
Frequently asked questions
Deify Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 November 2012 (14+ years old) and is registered under CIN U24233TG2012PTC083949.
Deify Pharma has 2 current directors:
- Lakshmi Vemulawada - Director
- Nichemolla Ramesh - Additional Director
The latest financial statements of Deify Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Deify Pharma is 36AAECD5341E1ZY, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Deify Pharma is U24233TG2012PTC083949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deify Pharma was incorporated on 01 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nichemolla Ramesh was appointed as Additional Director on 22 May 2025. Devidas Vemulawada ceased to be Director on 05 May 2025. Devidas Vemulawada was appointed as Director on 01 Nov 2012. Deify Pharma has 4 board changes on record in total.
Deify Pharma can be reached through the website deifypharma.com. Its registered office is in Secunderabad, Telangana, India.
The registered office of Deify Pharma is at Plot No 40 Anandnagar Colony Chinna Thokatta Bowenpally Secunderabad, Telangana, India – 500011.
Deify Pharma operates in the pharma industry, in the drug formulation and development segment.

